| Financial Year |
March 31 2023 |
| Monetary Funds |
20,100,814,229.17 |
| Held-for-trading Financial Assets |
102,400,415.74 |
| Notes Receivable |
-- |
| Accounts Receivable |
4,377,285,563.47 |
| Advances to Suppliers |
4,129,555,369.98 |
| Other Receivables |
3,588,247,990.32 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
54,519,829,400.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,320,998,972.28 |
| Total Current Assets |
94,642,550,324.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
8,855,956,020.26 |
| Investment Properties |
10,599,159.10 |
| Fixed Assetes |
218,903,063,812.73 |
| Under-construction Projects |
29,862,787,694.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,069,366,311.08 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
58,257.10 |
| Deferred Income Tax Assets |
1,089,764,199.93 |
| Other Non-Current Assets |
3,263,694,636.42 |
| Sub-Total of Non-Current Assets |
268,275,304,219.10 |
| Total Assets |
362,917,854,543.85 |
| Short-Term Loans |
41,792,736,878.58 |
| Trading Financial liabilities |
465,280,944.57 |
| Notes Payable |
3,386,983,606.35 |
| Accounts Payable |
48,588,982,874.74 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
484,321,770.06 |
| Taxes Payable |
1,095,659,010.15 |
| Interest Payable |
-- |
| Dividend Payable |
108,000,000.00 |
| Other payables |
3,346,409,135.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
19,209,154,858.60 |
| Other Current Liabilities |
759,012,390.86 |
| Sub-Total of Current Liabilities |
125,114,442,379.12 |
| Long-term Loans |
139,098,886,634.56 |
| Bonds Payable |
2,053,437,697.77 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,944,638,254.87 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
143,494,345,412.66 |
| Total Liabilities |
268,608,787,791.78 |
| Paid-In Capital(Or Share Stock) |
10,125,525,000.00 |
| Capital Surplus |
10,823,221,691.95 |
| Surplus Reserve |
886,470,394.72 |
| LESS:Treasury Stock |
3,978,202,364.65 |
| Undistributed Profits |
27,796,715,934.04 |
| Minority Stockholder's Interest |
48,500,044,922.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
45,809,021,829.22 |
| Owner's Equity（Stockholder's Equity） |
94,309,066,752.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
362,917,854,543.85 |
